Your browser doesn't support javascript.
loading
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.
Krieckaert, C L M; Nair, S C; Nurmohamed, M T; van Dongen, C J J; Lems, W F; Lafeber, F P J G; Bijlsma, J W J; Koffijberg, H; Wolbink, G; Welsing, P M J.
Afiliación
  • Krieckaert CL; Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
  • Nair SC; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nurmohamed MT; Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.
  • van Dongen CJ; Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
  • Lems WF; Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
  • Lafeber FP; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bijlsma JW; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Koffijberg H; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wolbink G; Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands.
  • Welsing PM; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Ann Rheum Dis ; 74(2): 361-8, 2015 Feb.
Article en En | MEDLINE | ID: mdl-24265411

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Medicina de Precisión / Anticuerpos Monoclonales Humanizados Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Medicina de Precisión / Anticuerpos Monoclonales Humanizados Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos